Sharp has a specific feel about how OTC companies should act. He has said several times that he doesn't like RS because the generally stick it to investors. I don't believe he will ever do that here. I believe if he was an advisor of a company, he would rather resign than be part of a RS there.
Right on! Your absolutely correct. Funny how the only things that get stickies are false opinionated statements. In the end the longs will come out on top. GRDO!